Change in Serum Biomarker CA 15-3 as an Early Predictor of Response to Treatment and Survival in Hypersensitivity Pneumonitis.

Sofia A MollI A WiertzA D M VorselaarsH J T RuvenC H M van MoorselJ C Grutters

Published in: Lung (2020)

Serum CA 15-3 correlates with PFT during 6 months of immunosuppressive therapy in HP. Interestingly, early CA 15-3 changes could predict future PFT. Furthermore, a decrease in CA 15-3 is related to longer survival. Therefore, serum CA 15-3 is a promising biomarker for implementation in HP care.

Keyphrases

healthcare
protein kinase
primary care
quality improvement
palliative care
pain management
chronic pain
drug induced
systemic sclerosis
idiopathic pulmonary fibrosis